MYLAN: Wins District Court Decision Against Biogen's Tecfidera® Patent
Mylan achieves key milestone to provide U.S. multiple sclerosis patients with more affordable generic version of Biogen's Tecfidera® capsules Read More »
Ernst introduces bill to bring pharmaceutical manufacturers back to U.S.
A bill introduced by U.S. Sen. Joni Ernst (R-IA) would give companies incentives if they brought their pharmaceutical, supply and medical device manufacturers back to the United States from China, the Ripon Advance reported. Read More »
ACELRX PHARMACEUTICALS: Announces Revised Merger Agreement with Tetraphase
Under revised terms, AcelRx to acquire Tetraphase for $37.0 million in stock and cash plus CVRs Read More »
U.S. considering international reference pricing for pharmaceutical drugs
International reference pricing (IRP) for drugs is under consideration in the U.S. as health care experts are discussing an International Society for Pharmacoeconomics and Outcomes Research (ISPOR) meeting to be held annually. Read More »
PHARMACISTS UNITED FOR TRUTH AND TRANSPARENCY: Independent Pharmacies Sue Major PBM Over Alleged Illegal Price Discrimination And Reimbursement Violations
The newest litigation against a major pharmacy benefit manager (PBM) comes from a likely source: its small business victims. Read More »
NICHE PHARMACEUTICALS: Recommends Use of Its Mag-Tab®SR to Help Offset Cardiac Issues
Adding Magnesium To Hydroxychloroquine, Azithromycin and Zinc Treatment Protocols May Offset Cardiac Issues(1,3) Read More »
EUROFINS DISCOVERY: Supports Critical COVID-19 Drug Discovery Research with Products and Accelerated Drug Discovery Services
Eurofins Discovery's mission is to support Pharmaceutical and Biotech companies in their efforts to accelerate drug discovery research and development. Read More »
CUMBERLAND PHARMACEUTICALS: To Help Prepare for the COVID-19 Patient Surge Cumberland Pharmaceuticals Expands Availability of Vaprisol® to Treat Hyponatremia in Critical Care Units
Vaprisol® safely and effectively addresses hyponatremia in the first 24 hours Read More »
NOVARTIS: New analysis further showed durable and potent LDL-C reduction with inclisiran, an investigational first-in-class siRNA cholesterol-lowering treatment
Prespecified analysis of pooled data from ORION-9, -10 and -11 Phase III clinical trials showed inclisiran reduced low-density lipoprotein-cholesterol (LDL-C) by 51% at 17 months Read More »
APHA: Urges Regulators to Revise Their Review Process of Healthcare Vertical Mergers
The American Pharmacists Association (APhA) submitted comments to the Federal Trade Commission (FTC) and the U.S. Department of Justice (DOJ) Antitrust Division addressing the impact vertical mergers are having on the pharmacy supply chain, medication pricing and patient access and choice. Read More »
Save on Prescriptions with ValpakRx
.jpg){kind=tracking}
As healthcare costs continue to rise in 2020, Valpak, a leader in local print and digital marketing, recently announced a new way to help their customers save on prescription drugs: ValpakRx. Read More »
CNS PHARMACEUTICALS: Completes Pilot Manufacturing Steps Pursuant to FDA Pre-IND Guidance
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biotechnology company specializing in the development of novel treatments for brain tumors, today announced that Anthem Biosciences of Bangalore, India (Anthem) has completed a pilot run of the recrystallization of the Reata Pharmaceuticals, Inc. API (Reata). Read More »
LOOPBACK ANALYTICS: Loopback Analytics and UF Health Jacksonville Working Together on Specialty Pharmacy to Improve Patient Outcomes
Loopback Analytics, a leading provider of data-driven solutions for hospital and health systems, announced today they are working with UF Health Jacksonville to help advance specialty pharmacy services. Read More »
E5 PHARMA: Launches First FDA Approved Generic For Proglycem®
.jpg){kind=tracking}
e5 Pharma, LLC., today announced the U.S. launch of Diazoxide, USP Oral Suspension, the first generic version of the reference listed drug, Proglycem®. e5 Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) using the Competitive Generic Therapy (CGT) Pathway. Read More »
REGENERON PHARMACEUTICALS: New England Journal of Medicine Publishes Results of Ebola Clinical Trial Confirming Superiority of Regeneron's REGN-EB3 to ZMapp in Preventing Ebola Deaths
Nearly 90 percent survival for patients who received REGN-EB3 treatment earlier in the course of their disease; 66.5 percent survival among all patients who received REGN-EB3 Read More »
BRYN PHARMA: Partners with Aptar Pharma for Nasal Epinephrine Treatment
Bryn's Epinephrine Nasal Spray has Two Doses in One Portable Device Read More »
PARTNER THERAPEUTICS: Receives Orphan Drug Designation for Leukine® (sargramostim)
Partner Therapeutics, Inc. (PTx), a commercial biotechnology company, announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Leukine® (sargramostim), a yeast-derived recombinant human granulocyte-macrophage colony stimulating factor (rhuGM-CSF), for the potential treatment of Stage IIb-IV melanoma. Read More »
DISPOSERX: Supports National Association of Chain Drug Stores' (NACDS) statement on the role of community pharmacies in solving the opioid crisis
Statement emphasizes the pharmacist's role in educating patients, including the importance of disposing of unused medication Read More »
TEVA PHARMACEUTICAL INDUSTRIES LTD.: Announces the Launch of a Generic Version of Delzicol® (mesalamine) Delayed-Release Capsules in the United States
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced the launch of a generic version of Delzicol®1 (mesalamine) delayed-release capsules, 400 mg, in the U.S. Read More »
AMERISOURCE BERGEN: US Bioservices Selected by Biocodex SAS to Exclusively Dispense DIACOMIT® (stiripentol)
AmerisourceBergen issued the following announcement on April 24.Original source can be found here. Read More »
Alerts Sign-up